Lung cancer patients’ CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells MK Srivastava, JJ Bosch, JA Thompson, BR Ksander, MJ Edelman, ... Cancer Immunology, Immunotherapy 57, 1493-1504, 2008 | 146 | 2008 |
Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80 ST Haile, JJ Bosch, NI Agu, AM Zeender, P Somasundaram, ... The Journal of Immunology 186 (12), 6822-6829, 2011 | 114 | 2011 |
Time-of-flight magnetic flow cytometry in whole blood with integrated sample preparation M Helou, M Reisbeck, SF Tedde, L Richter, L Bär, JJ Bosch, RH Stauber, ... Lab on a Chip 13 (6), 1035-1038, 2013 | 75 | 2013 |
Activation of Tumor-specific CD4+ T Lymphocytes by Major Histocompatibility Complex Class II Tumor Cell Vaccines: A Novel Cell-based Immunotherapy SK Dissanayake, JA Thompson, JJ Bosch, VK Clements, PW Chen, ... Cancer research 64 (5), 1867-1874, 2004 | 74 | 2004 |
Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva LM Heindl, C Hofmann-Rummelt, W Adler, JJ Bosch, LM Holbach, ... Ophthalmology 118 (12), 2351-2360, 2011 | 63 | 2011 |
The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes JA Thompson, MK Srivastava, JJ Bosch, VK Clements, BR Ksander, ... Cancer Immunology, Immunotherapy 57, 389-398, 2008 | 57 | 2008 |
Tumor-associated lymphangiogenesis in the development of conjunctival melanoma LM Heindl, C Hofmann-Rummelt, W Adler, JJ Bosch, LM Holbach, ... Investigative Ophthalmology & Visual Science 52 (10), 7074-7083, 2011 | 54 | 2011 |
Antigen-specific transfer of functional programmed death ligand 1 from human APCs onto CD8+ T cells via trogocytosis R Gary, S Voelkl, R Palmisano, E Ullrich, JJ Bosch, A Mackensen The Journal of Immunology 188 (2), 744-752, 2012 | 48 | 2012 |
MHC Class II–Transduced Tumor Cells Originating in the Immune-Privileged Eye Prime and Boost CD4+ T Lymphocytes that Cross-react with Primary and Metastatic Uveal Melanoma Cells JJ Bosch, JA Thompson, MK Srivastava, UK Iheagwara, TG Murray, ... Cancer Research 67 (9), 4499-4506, 2007 | 45 | 2007 |
Monitoring dynamic interactions of tumor cells with tissue and immune cells in a lab-on-a-chip V Charwat, M Rothbauer, SF Tedde, O Hayden, JJ Bosch, P Muellner, ... Analytical chemistry 85 (23), 11471-11478, 2013 | 38 | 2013 |
MHC II lung cancer vaccines prime and boost tumor‐specific CD4+ T cells that cross‐react with multiple histologic subtypes of nonsmall cell lung cancer cells MK Srivastava, JJ Bosch, AL Wilson, MJ Edelman, S Ostrand‐Rosenberg International journal of cancer 127 (11), 2612-2621, 2010 | 27 | 2010 |
Autocrine impact of VEGF-A on uveal melanoma cells KR Koch, N Refaian, D Hos, SL Schlereth, JJ Bosch, C Cursiefen, ... Investigative ophthalmology & visual science 55 (4), 2697-2704, 2014 | 25 | 2014 |
Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T … JJ Bosch, UK Iheagwara, S Reid, MK Srivastava, J Wolf, M Lotem, ... Cancer immunology, immunotherapy 59, 103-112, 2010 | 25 | 2010 |
A novel model of metastatic conjunctival melanoma in immune-competent mice SL Schlereth, S Iden, M Mescher, BR Ksander, JJ Bosch, C Cursiefen, ... Investigative Ophthalmology & Visual Science 56 (10), 5965-5973, 2015 | 24 | 2015 |
Comparing the hem-and lymphangiogenic profile of conjunctival and uveal melanoma cell lines N Refaian, SL Schlereth, KR Koch, M Notara, D Hos, M Mescher, S Iden, ... Investigative Ophthalmology & Visual Science 56 (9), 5691-5697, 2015 | 20 | 2015 |
Impaired transmigration of myeloid-derived suppressor cells across human sinusoidal endothelium is associated with decreased expression of CD13 YJ Resheq, AK Menzner, J Bosch, J Tickle, KK Li, A Wilhelm, E Hepburn, ... The Journal of Immunology 199 (5), 1672-1681, 2017 | 12 | 2017 |
The Trojan horse tale revisited: an eye on metastatic spread of carcinoma cells RS Grajewski, JJ Bosch, H Bruns, C Cursiefen, LM Heindl Cancer Immunology Research 4 (2), 92-94, 2016 | 10 | 2016 |
Immunotherapy of uveal melanoma JJ Bosch Current Concepts in Uveal Melanoma 49, 137-149, 2012 | 10 | 2012 |
The novel role of lymphatic vessels in the pathogenesis of ocular diseases T Clahsen, K Hadrian, M Notara, SL Schlereth, A Howaldt, V Prokosch, ... Progress in Retinal and Eye Research 96, 101157, 2023 | 9 | 2023 |
Current management of uveal melanoma: A review H Bai, JJ Bosch, LM Heindl Clinical & Experimental Ophthalmology 51 (5), 484-494, 2023 | 9 | 2023 |